Share

cover art for Kat Murti: Stop the DEA From Scheduling DOI & DOC

Mycopreneur

Kat Murti: Stop the DEA From Scheduling DOI & DOC

Season 3

Kat Murti is the Executive Director of SSDP, Students For Sensible Drug Policy, an advocacy org working to end the War On Drugs and ensure access to research and civil liberties. She joins us today to raise public awareness of the proposed scheduling of DOI and DOC by the United States Drug Enforcement Administration. DOI and DOC are two research chemicals that are vitally important to psychedelic research - SSDP is taking the DEA to court to ensure that these two chemicals remain unscheduled, a process which we discuss on the episode today in addition to covering a lot of ground around drug policy reform and the War On Drugs history and aims at large.


Please rate and review this episode wherever you're listening.

More episodes

View all episodes

  • Anne Philippi: The New Health Institute Fundraising Approach

    54:59|
    Anne Phillippi is the Founder of The New Health Institute and a journalist with decades of experience working with major brands and celebrities. She joins the Mycopreneur Podcast today to discuss the need for elevating the way that non-profits in the psychedelic space approach fundraising, why there should be a Met Gala for psychedelics, and how to navigate the burden of digital censorship when discussing psychedelics online. Follow her work on SusbtackThis episode is brought to you by Mycogenius, fully traceable, third-party tested functional mushroom extractsand by Full Canopy Genetics, the only isolated genetics for mushroom grow bags
  • Charles Patti: Extended State DMT at Eleusis

    48:46|
    Charles Patti is one of the Co-Founders of Eleusis, a luxury psychedelic immersion center located on the Caribbean isle of St. Vincent and The Grenadines.We learn about the extended state DMT protocol which is actively being administered to guests at the beachfront luxury clinic thanks to a government license, as well as the broader vision guiding the work at Eleusis. This episode is brought to you by Full Canopy Genetics and by Mycogenius
  • Travis Tyler Fluck: Giving Away 400 Therapeutic Doses of Psilocybin Mushrooms For Free In Aspen

    36:28|
    Travis Tyler Fluck was instrumental in laying the groundwork for the passage of decriminalization of entheogenic fungi in Denver, and he's been deeply involved in the community there for the arc of Prop 122 and the Natural Medicine Health Act. Today he returns to the Mycopreneur Podcast to share about his upcoming appearance at the Aspen Psychedelic Symposium where he'll be gifting 400 therapeutic level doses of psilocybin mushrooms away to attendees for free. The total cost of inputs and production of the 400 doses costs Travis was able to produce each dose for .43 cents each, totaling less than one person undergoing one licensed and legal psilocybin mushroom therapy session under the state-regulated framework.This episode is brought to you by Full Canopy GeneticsThis episode is also brought to you by Mycogenius
  • Mycogenius: Mushroom Industry & Culture in the European Union

    39:07|
    Seth Colchester is the Founder of Mycogenius, a Netherlands-based manufacturer of premium functional mushroom extracts that are third-party tested and fully traceable. He is also the founder of Functionalmushrooms.eu, a wholesale provider of premium functional mushroom extracts and white labeling service for international brands.Seth joins me today to discuss the mushroom industry in the EU in regards to culture, regulations, and market opportunity as it currently stands.Please rate and review this podcast on whichever platform you're listening you're listening ( :
  • Shelby Hartman: The DoubleBlind Guide to Psychedelics

    36:24||Season 4
    Shelby Hartman is a journalist best known as the Co-Founder of the pre-eminent psychedelic media platform DoubleBlind.Today she returns to the Mycopreneur Podcast to discuss the evolution of the psychedelic media landscape as well as shifting public perceptions of psychedelics over the last decade since she helped launch one of the first prominent independent media platforms covering the subject. We also discuss the new book she co-authored with her DoubleBlind Co-Founder Madison Margolin titled "The DoubleBlind Guide to Psychedelics: A Roadmap to Tripping, Microdosing, and Beyond"This episode is brought to you by Mycogenius, third-party tested and fully traceable premium functional mushroom extracts
  • Lee Carroll: Ergothioneine in Support of Psychedelic Therapy

    48:38|
    Lee Carroll returns to the Mycopreneur Podcast to discuss his novel research into Ergothioneine as a support framework for psychedelic therapy and neuroplasticity. Lee unpacks complex concepts like the BDNF pathway, cellular phosphorylation, and the transformative power of hydrogen sulfide at the cellular level in digestible phrasing for non-clinicians. This episode is brought to you by Real MushroomsPlease rate and review this episode on whichever platform you're listening
  • Adam Miezio: Psychedelics in the Epstein Files

    50:36||Season 4
    Adam Miezio is a journalist and content marketer in the psychedelic space who serves as the Guild Master of the Psychedelic Writers Guild and the writer behind The Divine Influx on Substack among other roles. Today we discuss the state of psychedelic journalism and dive down the rabbit hole of the connection between psychedelics and the Epstein Files in addition to other interesting topics at the intersection of psychedelics and largely untold stories. Please rate and review this episode wherever you're listening
  • Robert Gallery: Ibogaine For Athletes with Traumatic Brain Injuries

    33:54||Season 4
    Robert Gallery is an NFL veteran who is the Founder of Athletes For Care, an organization supporting research, advocacy, and real solutions for athlete mental health. He joins me today to discuss his transformation from a retired NFL star with severe mental health issues to a pioneer in the psychedelic therapy advocacy and research space for athletes. This episode was recorded several weeks prior to the recent Executive Order signed by President Trump which fast-tracks psychedelic research for 'Breakthrough Therapies' including Ibogaine. Please rate and review this episode wherever you're listening
  • Melanie Tremblay: The Hidden Dangers of AI-Generated Mushroom Claims

    46:56||Season 4
    Melanie Tremblay is the Chief Operating Officer of Real Mushrooms, one of the most reputable and influential mushroom companies in North America. She draws from her background in the beauty and cosmetics industry to discuss advertising trends and exaggerated claims as well as flat out misinformation in the functional mushroom industry today as it continues to grow into a major category. Please rate and review this episode wherever you're listening